Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.55 - $3.49 $382,140 - $523,007
149,859 New
149,859 $449,000
Q3 2022

Nov 14, 2022

BUY
$0.55 - $0.9 $9,680 - $15,840
17,600 New
17,600 $10,000
Q2 2021

Aug 16, 2021

SELL
$2.16 - $3.18 $60,264 - $88,722
-27,900 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$2.89 - $4.22 $84,243 - $123,013
-29,150 Reduced 51.1%
27,900 $84,000
Q4 2020

Feb 16, 2021

BUY
$2.69 - $4.24 $153,464 - $241,892
57,050 New
57,050 $215,000
Q3 2019

Nov 14, 2019

SELL
$2.8 - $12.85 $1.39 Million - $6.37 Million
-495,515 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$10.6 - $13.12 $540,123 - $668,529
-50,955 Reduced 9.32%
495,515 $5.91 Million
Q1 2019

May 15, 2019

SELL
$9.96 - $13.44 $487,203 - $657,431
-48,916 Reduced 8.22%
546,470 $6.81 Million
Q4 2018

Feb 14, 2019

BUY
$8.47 - $14.71 $1.55 Million - $2.7 Million
183,391 Added 44.51%
595,386 $5.64 Million
Q3 2018

Nov 14, 2018

BUY
$13.7 - $17.12 $4.87 Million - $6.08 Million
355,329 Added 627.06%
411,995 $5.93 Million
Q2 2018

Aug 14, 2018

BUY
$14.63 - $19.19 $829,023 - $1.09 Million
56,666 New
56,666 $914,000

Others Institutions Holding GLYC

About GLYCOMIMETICS INC


  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $13.6M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.